Augmedix Announces Participation in Maxim Group Healthcare IT Investor Conference on January 25
Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company, announced its participation in the Maxim Group Virtual Healthcare IT Conference on January 25, 2023.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company, announced its participation in the Maxim Group Virtual Healthcare IT Conference on January 25, 2023. CEO Manny Krakaris will join a live webcast Doctor's Panel at 12:30 p.m. ET, while CFO Paul Ginocchio will conduct investor meetings throughout the day. The company provides ambient medical documentation solutions that enhance clinician-patient interactions by converting conversation into real-time medical notes. Augmedix aims to reduce clinician burnout and improve overall patient care through its innovative platform that leverages automated speech recognition and natural language processing.
Positive
- Participation in Maxim Group Virtual Healthcare IT Conference can enhance investor relations and visibility.
- Innovative solutions to reduce clinician burnout and improve patient satisfaction may lead to future growth.
Negative
- None.
Details
News Market Reaction – AUGX
The recorded move for AUGX in the trading session of this news was +6.41%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN FRANCISCO, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced that its leadership team will participate in the Maxim Group Virtual Healthcare IT Conference on Wednesday, January 25, 2023. Manny Krakaris, Chief Executive Officer, will join the “Doctors Panel” which will be webcast live at 12:30 p.m. ET. Mr. Krakaris and Paul Ginocchio, Chief Financial Officer, will also host investor meetings throughout the day.
To register for the conference and schedule a meeting, visit the conference portal here. Investors interested in arranging a meeting can also contact FNK IR at augx@fnkir.com or their Maxim Group representative.
About Augmedix
Augmedix, Inc. (Nasdaq: AUGX) delivers industry-leading, ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners.
Augmedix is on a mission to help clinicians and patients form a human connection at the point of care without the intrusion of technology. Augmedix’s solutions extract data from natural physician-patient conversations and convert it to medical notes in real time, which are seamlessly transferred to the EHR. To achieve this, the company’s Ambient Automation Platform uses Automated Speech Recognition and Natural Language Processing, supported by medical documentation specialists.
Leveraging this platform, Augmedix’s solutions relieve clinicians of administrative burden, in turn, reducing burnout and increasing both clinician and patient satisfaction. Augmedix is also leading the revolution in leveraging point-of-care data by making connections between millions of physician-patient interactions and analyzing them to deliver actionable insights that elevate patient care.
Augmedix is headquartered in San Francisco, CA, with offices around the world. To learn more, visit augmedix.com.
Contact Information
Investors:
Matt Chesler, CFA
FNK IR
(646) 809-2183
augx@fnkir.com
investors@augmedix.com
Media:
Kaila Grafeman
Augmedix
pr@augmedix.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.